High dose weekly erlotinib achieves therapeutic concentrations in CSF and is effective in leptomeningeal metastases from epidermal growth factor receptor mutant lung cancer Journal Article


Authors: Clarke, J. L.; Pao, W.; Wu, N.; Miller, V.; Lassman, A. B.
Article Title: High dose weekly erlotinib achieves therapeutic concentrations in CSF and is effective in leptomeningeal metastases from epidermal growth factor receptor mutant lung cancer
Abstract: Leptomeningeal metastases (LM) occur in 5-10% of patients with solid tumors and are associated with a dismal prognosis. We describe LM from lung adenocarcinoma harboring a mutation in the epidermal growth factor receptor (EGFR) gene that confers sensitivity to the EGFR tyrosine kinase inhibitors (EGFR-TKIs) erlotinib and gefitinib. The CSF concentration of EGFR-TKIs achieved by standard daily dosing may be insufficient for therapeutic effect. However, intermittent (pulsatile) high dose administration (1000-1500 mg/week) achieves a higher CSF concentration than standard dosing, and successfully controlled LM in this patient. © 2010 Springer Science+Business Media, LLC.
Keywords: adult; treatment outcome; middle aged; gene mutation; mutation; case report; erlotinib; drug dose comparison; paclitaxel; temozolomide; drug megadose; adenocarcinoma; carboplatin; lung non small cell cancer; lung neoplasms; epidermal growth factor receptor; lung cancer; receptor, epidermal growth factor; cetuximab; protein kinase inhibitors; lung adenocarcinoma; meningeal neoplasms; gefitinib; brain metastasis; egfr; quinazolines; drug sensitivity; pemetrexed; leptomeningeal metastases; drug cerebrospinal fluid level; leptomeningeal metastasis
Journal Title: Journal of Neuro-Oncology
Volume: 99
Issue: 2
ISSN: 0167-594X
Publisher: Springer  
Date Published: 2010-09-01
Start Page: 283
End Page: 286
Language: English
DOI: 10.1007/s11060-010-0128-6
PUBMED: 20146086
PROVIDER: scopus
PMCID: PMC3973736
DOI/URL:
Notes: --- - "Cited By (since 1996): 4" - "Export Date: 20 April 2011" - "CODEN: JNODD" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. William Pao
    141 Pao
  2. Jennifer L Clarke
    11 Clarke
  3. Andrew Lassman
    111 Lassman
  4. Vincent Miller
    270 Miller
  5. Nian Wu
    32 Wu